Depo-Provera Lawsuit

Depo-Provera Lawsuit: What You Need to Know About Risks and Legal Claims

Depo-Provera has long been a popular contraceptive option, used by millions worldwide for both birth control and treating conditions like endometriosis. However, recent lawsuits against Pfizer, the drug’s manufacturer, highlight potential risks associated with long-term Depo-Provera use, particularly an increased risk of developing meningioma—a type of brain tumor. Here’s what these lawsuits involve, who may qualify, and how Berry Law may be able to help.

Background on Depo-Provera

Depo-Provera, or Depot medroxyprogesterone acetate (DMPA), has been used for contraception in the U.S. since its approval in 1992. Given as an injection every three months, Depo-Provera also provides relief for conditions like abnormal uterine bleeding and certain cancers. However, recent studies and claims suggest that the drug’s active ingredient, a synthetic progestin, may be associated with a higher risk of meningioma when used over long periods.

Health Risks and Study Findings

A 2024 study published in the British Medical Journal observed that women who received Depo-Provera injections over an extended period had a 5.6-fold increased risk of developing meningioma tumors. Although these tumors are typically benign, they can lead to severe complications—such as headaches, vision changes, and memory issues—that may require surgical intervention. Some plaintiffs argue that Pfizer was aware, or should have been aware, of these risks and that clearer warnings could have allowed them to make more informed health choices.

Allegations Against Pfizer

The lawsuits against Pfizer generally claim:

• Failure to Warn: Pfizer allegedly did not adequately inform Depo-Provera users or healthcare providers about the potential risk of brain tumors.
• Negligent Marketing and Testing: Plaintiffs argue that Pfizer did not sufficiently research the risks of long-term progestin-only contraceptive use.
• Medical Harm: Many women claim they would have reconsidered their contraceptive choices if they had known about the associated risks.

Lawsuit Eligibility and Criteria

To qualify for a Depo-Provera lawsuit with Berry Law, certain criteria must be met:

• Products Used: The lawsuit applies to women who used brand-name Depo-Provera, Depo-SubQ Provera, or authorized generics manufactured by companies like Greenstone and Pharmacia & Upjohn.
• Usage Frequency: Plaintiffs must have received at least two injections.
• Diagnosis: Qualifying cases involve a diagnosis of meningioma or another benign brain tumor following Depo-Provera use.

What’s Next in the Depo-Provera Litigation

These cases are in the early stages and may be consolidated into multidistrict litigation (MDL), allowing for a more coordinated handling of similar claims. Potential outcomes could include settlements, updated warnings, or additional research on Depo-Provera’s long-term safety. At Berry Law, we are currently accepting new cases and closely monitoring developments in these cases to support clients in making informed legal decisions.

Berry Law: Your Partner in the Fight for Justice

At Berry Law, we fight for those whose health may have been impacted by negligence. If you or someone you love has developed meningioma after Depo-Provera use, reach out to Berry Law. We’re here to provide guidance, pursue your legal options, and fight relentlessly for the compensation you deserve.

Stay Informed

Protecting your health starts with information. Follow updates from trusted sources like the FDA and legal news platforms to make empowered decisions about your contraceptive choices and legal rights.

For further guidance, contact Berry Law today to discuss your case and explore the path to justice.